OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 122 filers reported holding OREXIGEN THERAPEUTICS INC in Q2 2013. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $751,000 | +622.1% | 95,900 | +458.9% | 0.00% | +300.0% |
| Q4 2014 | $104,000 | -50.7% | 17,159 | -47.0% | 0.00% | -50.0% |
| Q1 2014 | $211,000 | +142.5% | 32,398 | +110.4% | 0.00% | +100.0% |
| Q4 2013 | $87,000 | -70.3% | 15,400 | -69.3% | 0.00% | -66.7% |
| Q2 2013 | $293,000 | – | 50,135 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 525,000 | $2,956,000 | 1.06% |
| First Light Asset Management, LLC | 170,804 | $962,000 | 0.82% |
| PFM Health Sciences, LP | 5,047,119 | $28,415,000 | 0.57% |
| Rhenman & Partners Asset Management AB | 250,000 | $1,408,000 | 0.55% |
| NEA Management Company, LLC | 1,935,300 | $10,896,000 | 0.53% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 544,779 | $3,067,000 | 0.43% |
| APEX CAPITAL, LLC | 1,000,000 | $5,630,000 | 0.37% |
| Partner Investment Management, L.P. | 240,221 | $1,352,000 | 0.31% |
| Hudson Bay Capital Management LP | 1,002,405 | $5,644,000 | 0.23% |
| BAILARD, INC. | 243,300 | $1,370,000 | 0.22% |